# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007964
Filing Date
2024-05-13
Accepted
2024-05-13 16:17:29
Documents
91
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cara-20240331x10q.htm iXBRL | 10-Q | 1765368
2 | EX-31.1 | cara-20240331xex31d1.htm | EX-31.1 | 12305
3 | EX-31.2 | cara-20240331xex31d2.htm | EX-31.2 | 11345
4 | EX-32.1 | cara-20240331xex32d1.htm | EX-32.1 | 11208
| Complete submission text file | 0001558370-24-007964.txt |  | 8563961

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | cara-20240331.xsd | EX-101.SCH | 67249
6 | EX-101.CAL | cara-20240331_cal.xml | EX-101.CAL | 59128
7 | EX-101.DEF | cara-20240331_def.xml | EX-101.DEF | 295507
8 | EX-101.LAB | cara-20240331_lab.xml | EX-101.LAB | 529600
9 | EX-101.PRE | cara-20240331_pre.xml | EX-101.PRE | 450024
95 | EXTRACTED XBRL INSTANCE DOCUMENT | cara-20240331x10q_htm.xml | XML | 1483465

Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 24939310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)